Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-04-07 Director's Dealing
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
112年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares (e.g., ordinary shares, trust shares, pledged shares). The content is focused on insider share transactions and holdings rather than financial results, management commentary, or corporate governance policies. There is no indication of it being a full annual or quarterly report, earnings release, or any other type of report. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider holdings and changes, confirming it is not a mere announcement or certification.
2023-04-07 Chinese
112年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings of company insiders, including directors and senior management, with specific numbers of shares held, pledged shares, and related parties' holdings. It is a disclosure of insider shareholdings and their changes, typical of a Director's Dealing or insider shareholding notification. There is no indication of financial statements, audit information, or meeting materials. The document is not a report or announcement of voting results, nor a regulatory filing of other types. Given the detailed insider shareholding data, the best fit is Director's Dealing (DIRS). The document length is short (2491 characters), consistent with a shareholding disclosure rather than a full report.
2023-04-07 Chinese
112年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (科妍) providing information about fund loans and endorsement guarantees, all showing zero balances. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of routine regulatory filings in Taiwan's public information observation station. The document is short (601 characters) and contains no financial statements or detailed analysis, only summary data. It does not fit into categories like Annual Report, Interim Report, or Capital Update. It is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2023-04-07 Chinese
112年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (764 characters), and it appears to be a brief financial summary rather than a full report. It does not announce a report publication nor is it a certification or regulatory filing. Given the nature of the content as a brief financial summary, it best fits the category of Fund Information / Factsheet (FS), which is for brief summaries of key company financials and market info.
2023-04-07 Chinese
111年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table summarizing key financial ratios and metrics for the company 科妍 over three fiscal years (109年度, 110年度, 111年度). The data includes solvency, profitability, turnover ratios, and cash flow ratios. The document is relatively short (1014 characters) and appears to be a summary or analysis of recent financial data rather than a full financial report. There is no indication that this is a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It also does not contain management discussion or detailed narrative. The document resembles a brief financial factsheet or summary of key financial data for investors or public disclosure. Therefore, the best fitting category is Fund Information / Factsheet (FS).
2023-03-22 Chinese
111年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific quarter (111年4季, which corresponds to Q4 of year 111 in the Taiwanese calendar). The content is tabular and concise, focusing on investment details rather than a full financial report. The document length is only 662 characters, indicating it is a short disclosure rather than a comprehensive report. There is no indication that this is an announcement of a report publication or a certification. The content fits best with a Regulatory Filing (RNS) as it is a regulatory disclosure of investment information without full financial statements or detailed analysis. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-03-22 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.